BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Gold ‘Nanoprobes’ Used To Track Blood Flow In Tiny Vessels, University of Birmingham Reveals

  October 13, 2017

   · 

  1 min read
• Pharm Country

  We May Soon Have Our First $1 Million Drug. Who Will Pay For It? And How?

  October 13, 2017

   · 

  1 min read
• Biotech Bay

  Are Analysts Secretly Calling Gilead A Screaming Buy?

  October 13, 2017

   · 

  1 min read
• 

  Policy

  Antares Pharma Implodes After FDA Responds to Its Xyosted NDA

  October 13, 2017

   · 

  2 min read
• Business

  Boston Scientific, Mayo Clinic File Joint Patent App for Self-Centering TAVR Cath

  October 13, 2017

   · 

  1 min read
• 

  Job Trends

  Big Pharmas are Poaching Top Talent From Tech Giants Like Google and LinkedIn

  October 13, 2017

   · 

  2 min read
• BioCapital

  Fertility Tests Are A Waste Of Money: Ovarian Reserve Debunked By NIH

  October 13, 2017

   · 

  1 min read
• Business

  Baxter International Expects Hit on Q4 Revenue Due to Hurricane Maria

  October 13, 2017

   · 

  7 min read
• 

  Business

  Massachusetts’ Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives

  An investor decision to renege on acquiring more than $3 million worth of stock has created a financial catastrophe for Biostage.

  October 13, 2017

   · 

  3 min read
• 

  Job Trends

  Booming Bay Area Biotechs’ Huge Headache: Where to House Their Employees

  The San Francisco Bay Area, and South San Francisco in particular, is a fast-growing area for the biotech industry.

  October 13, 2017

   · 

  3 min read